Ziv Zhang
About Ziv Zhang
Ziv Zhang is the Regional Manager for BeiGene in Northern China, with extensive experience in market access and pricing within the biopharmaceutical industry.
Regional Manager at BeiGene
Ziv Zhang currently holds the position of Regional Manager at BeiGene, specializing in hematology oncology. In this role, Ziv oversees operations in Northern China, leveraging extensive market access and pricing experience within the biopharmaceutical industry. The position at BeiGene exemplifies Ziv's ability to manage and drive business initiatives in innovative medicines.
Previous Experience at Johnson & Johnson
Before joining BeiGene, Ziv Zhang worked at Johnson & Johnson in various roles. From 2022 to 2023, Ziv served as a Senior District Manager in Oncology for Eastern China. Earlier in 2022, Ziv was a District Manager in the same region, also specializing in oncology. In 2021, Ziv held the position of Account Manager in Immunology for Eastern China. These roles significantly contributed to Ziv's expertise in the biomedical field, especially in market access and pricing.
MBA Associate at Pfizer
Ziv Zhang worked at Pfizer as an MBA Associate in 2019, accumulating 11 months of experience in Manhattan, New York. The role at Pfizer allowed Ziv to gain valuable insights into the biopharmaceutical industry, further developing expertise in business management and strategic market planning.
MBA Education at Columbia Business School
Ziv Zhang earned a Master of Business Administration (MBA) from Columbia Business School, where he studied from 2018 to 2020. Ziv's MBA education was complemented by a cross-registration at Columbia University Vagelos College of Physicians and Surgeons, combining strong business acumen with medical knowledge. This educational background has been instrumental in Ziv's career trajectory in the biopharmaceutical and healthcare sectors.
Consulting Roles at Deloitte
Ziv Zhang's career includes substantial consulting experience at Deloitte. Beginning as an Analyst in Beijing from 2014 to 2016, Ziv was promoted to Consultant from 2016 to 2017, and subsequently to Senior Consultant from 2017 to 2018 in Central, Hong Kong. These roles provided a solid foundation in strategy and corporate finance, which later facilitated Ziv's transition to the biopharmaceutical industry.